Table of Content

Strategic Imperatives
Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Gut Microbiome Market
Growth Opportunities Fuel the Growth Pipeline Engine™
Growth Opportunity Analysis
Introduction
Growth Drivers
Growth Driver Analysis
Growth Restraints
Growth Restraints Analysis
Scope of Analysis
Segmentation
Research Methodology
Regulatory Landscape
Regulatory Landscape for Microbiome in Europe
Regulatory Landscape for Microbiome in Europe (continued)
Regulatory Landscape for Microbiome across the Asia-Pacific
Regulatory Landscape for Microbiome across the Asia-Pacific (continued)
Regulatory Landscape for Microbiome in North America
Summary of Global Probiotic Regulations
Untargeted Approaches (Clinical Trials Analysis)
Untargeted Approaches for Treating Oncology Conditions
Untargeted Approaches for Treating Gastrointestinal Conditions
Untargeted Approaches for Treating Metabolic Conditions
Untargeted Approaches for Treating Neurological Conditions
Untargeted Approaches for Treating Other Conditions
Analyst Insight—Untargeted Approaches
Targeted Approaches (Clinical Trials Analysis)
Targeted Approaches for Treating Oncology Conditions
Targeted Approaches for Treating Gastrointestinal Conditions
Targeted Approaches for Treating Neurological Conditions
Targeted Approaches for Treating Other Conditions
Analyst Insights—Targeted Approach
Analyst Insights—Targeted Approach (continued)
Innovation Ecosystem
Innovation Spotlight in Untargeted Approach
Innovation Spotlight in Targeted Approach
Innovation Spotlight in Targeted Approach (continued)
R&D Activities (Basic/Applied and Exploratory Research)
Research Landscape: Analyst Insights
Research Landscape: Analyst Insights (continued)
Increasing Collaborations and Partnerships to Promote the Development of Gut Microbiome Therapeutics
Increasing Collaborations and Partnerships to Promote the Development of Gut Microbiome Therapeutics (continued)
Increasing Collaborations and Partnerships to Promote the Development of Gut Microbiome Therapeutics (continued)
IP and Funding
Patent Landscape for Microbiome Industry
Patent Landscape for Microbiome Industry (continued)
Significant Venture Capital and Private Equity Funding Boost Innovations in the Gut Microbiome Industry
Government Grant Funding Supporting Innovations in the Gut Microbiome Industry
Growth Opportunity Universe
Growth Opportunity 1: Gut Microbiome Targeted Approaches
Growth Opportunity 1: Gut Microbiome Targeted Approaches (continued)
Growth Opportunity 2: Gut-Brain Axis Applications
Growth Opportunity 2: Gut-Brain Axis Applications (continued)
Growth Opportunity 3: Oncological Applications
Growth Opportunity 3: Oncological Applications (continued)
Legal Disclaimer